← Leaderboards
Matt Surman
Albany Molecular Research, Inc.
$1,796,372
Attributed
$1,796,372
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $728.8K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,796,372 · 1
By mechanism
N01$1,796,372 · 1
Top collaborators
No co-investigators on record.
Most similar at Albany Molecular Research, Inc.
Same institution · by research overlap
- Keith Barnes$45,425,605
- John Reilly$2,579,604
- Melissa Allard$16,991,646
- Carrie Costello$1,542,434
- Brian Penny$907,791
Others in their field
Other Rising Stars on “Absorption”
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Alexander Kolykhalov · Emory University$8,116,465
- Anil Gupta · Scripps Research Institute, The$7,340,144
- Debra Burnin · Sri International$7,194,143
- David Burkhart · Inimmune Corporation$5,907,864
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$5,835,304
Research focus
AbsorptionAreaAwardChemistryClinical PainComputational ChemistryComputer AssistedContractorContractsDesignDrug DiscoveryExcretory FunctionHelping To End Addiction Long-TermIn VitroLeadLogisticsMetabolismNovel TherapeuticsPainPain ManagementParentsPerformanceProdrugsShipping
Grant awards (3)
HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I$611,149
N01 · FY2025 · DA · contact PI
HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I$456,391
N01 · FY2024 · DA · contact PI
HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I$728,832
N01 · FY2022 · DA · contact PI